Professional Documents
Culture Documents
Vecuronium
Vecuronium
Vecuronium
Norcuron
PEAK
3-5 min
2.5-3 min
25-40 min
Pediatric -IV: 0.08-0.1 mg/kg Adult- IV: 0.08-0.1 mg/kg Continuous infusion: 0.1 mg/kg/hr
LAB VALUE ALTERATIONS None listed DRUG INTERACTIONS
Aminoglycosides, Calcium channel blockers, clindamycin, cyclophosphamide, cyclosporine ,dantrolene ,furosemide, Inhalation anesthetics ,Local anesthetics,magnesium ,polymyxin, procainamide ,quinidine
Why is your patient getting this medication? Or What are some reasons that these medications are ordered? Pediatric- Intubation
Nondepolarizing NMBDs also bind to ACh receptors at the neuromuscular junction, but instead of mimicking ACh, they block its usual actions. Therefore, these drugs are competitive antagonists of ACh. Consequently, the nerve cell membrane is not depolarized, the muscle fibers are not stimulated, and skeletal muscle contraction does not occur.
COMMON SIDE EFFECTS
Musculoskeletal: skeletal muscle weakness. Respiratory: prolonged, dose-related respiratory insufficiency or apnea.
TEACHING
PREADMINISTRATION ASSESSMENT?